Skip to main content
Premium Trial:

Request an Annual Quote

Paul Meister, John Sharp, Samuel Mitchell

Paul Meister said this week that he will not stand for reelection as chairman of the board of Thermo Fisher Scientific at the firm’s annual meeting on May 15. In anticipation of his retirement, Meister has already relinquished his position as chairman. The firm did not say whether any of the other directors have assumed his duties.
Thermo Fisher said it expects to identify a new director prior to its upcoming meeting.

John Sharp, vice president of finance for Sequenom, notified the firm that he would leave the firm on April 17, according to a regulatory filing last week.

Samuel Mitchell, a senior scientist at an agriculture and biotechnology facility in Belfast, Northern Ireland, has won an HPLC system and a TOF LC mass spectrometer through an Agilent Technologies European sweepstakes, Agilent said this week.
Mitchell, of the Agri-Food & Biosciences Institute, won a 1200 Series liquid chromatography system and a 6510 Quadrupole Time-of-Flight LC/mass spectrometer, Agilent said. The company valued Mitchell’s winnings at $525,000. 
Mitchell said the new technology “will enhance [the institute’s] technical capabilities thus helping us with future funding applications.”

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.